{"content":"<li class=\"n-box-item date-title\" data-end=\"1381377599\" data-start=\"1381291200\" data-txt=\"Friday, December 20, 2019\">Wednesday, October  9, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1321722\" data-ts=\"1381363789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRXI\" target=\"_blank\">PRXI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321722-premier-exhibitions-hits-iceberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premier Exhibitions hits iceberg</a></h4><ul>\n<li>In addition to <a href=\"https://seekingalpha.com/currents/post/1321622\" target=\"_blank\">weak FQ2 operating results</a>, the company's sale of its Titanic assets has fallen through, with Premier (<a href=\"https://seekingalpha.com/symbol/PRXI\" title=\"Premier Exhibitions, Inc.\">OTC:PRXI</a>) terminating the non-binding LOI with the Hampton Roads consortium effective today.</li>\n<li>Premier has attracted value and special situation types who argued the Titanic assets made the stock a buy even if attaching zero value to the company's operating business and balance sheet cash.</li>\n<li>The collapse of the deal could hardly be a total surprise to investors and tomorrow's action may give an idea of whether the near-50% decline in the shares over the last six months has priced it in.</li>\n<li>From April: The <a href=\"https://seekingalpha.com/article/1309391-will-premier-exhibitions-titanic-auction-go-on-and-on\" target=\"_blank\">bull case</a> from SA Pro's Chris DeMuth, and the (thus far correct) <a href=\"https://seekingalpha.com/article/1321981-has-premier-exhibitions-titanic-sale-sunk\" target=\"_blank\">bear rebuttal</a> from Squeeky Wheel.</li>\n<li>From this summer: Why Premier may work <a href=\"https://seekingalpha.com/article/1506432-failed-titanic-sale-wont-sink-premier-exhibitions\" target=\"_blank\">even without </a>the Titanic Sale from SA Pro's Whopper Investments, and Squeeky Wheel <a href=\"https://seekingalpha.com/article/1607802-time-to-board-premier-exhibitions-titanic\" target=\"_blank\">beginning to turn bullish</a> after the collapse in the stock price.</li>\n<li>Shares <font color=\"red\">-3.3%</font> AH to $1.46 in very thin trading.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1321722\" data-linked=\"Premier Exhibitions hits iceberg\" data-tweet=\"$PRXI - Premier Exhibitions hits iceberg https://seekingalpha.com/news/1321722-premier-exhibitions-hits-iceberg?source=tweet\" data-url=\"https://seekingalpha.com/news/1321722-premier-exhibitions-hits-iceberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321652\" data-ts=\"1381356274\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMU\" target=\"_blank\">IMMU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321652-immunomedics-takeda-licensing-deal-terminated-immu-minus-6_8-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immunomedics-Takeda licensing deal terminated, IMMU -6.8% AH</a></h4><ul>\n<li>Takeda Pharmaceutical has notified Immunomedics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/IMMU\" title=\"Immunomedics, Inc.\">IMMU</a>) it's terminating a licensing deal between Takeda's Nycomed subsidiary and Immunomedics for worldwide rights to the latter's <a href=\"http://www.immunomedics.com/veltuzumab.shtml\" target=\"_blank\">Veltuzumab</a> antibody drug for non-cancer uses. (PR)</li>\n<li>Immunomedics says the notification was received after the company filed for arbitration proceedings in a dispute with Nycomed over delays in Veltuzumab development, arguing the delays amount to a \"material breach\" of the licensing deal.</li>\n<li>All rights to Veltuzumab revert back to Immunomedics. The company plans to continue pursuing its arbitration case as it works with Nycomed to fully transition Veltuzumab sales back to Immunomedics.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1321652\" data-linked=\"Immunomedics-Takeda licensing deal terminated, IMMU -6.8% AH\" data-tweet=\"$IMMU - Immunomedics-Takeda licensing deal terminated, IMMU -6.8% AH https://seekingalpha.com/news/1321652-immunomedics-takeda-licensing-deal-terminated-immu-minus-6_8-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1321652-immunomedics-takeda-licensing-deal-terminated-immu-minus-6_8-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321592\" data-ts=\"1381354603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321592-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours Gainers / Losers</a></h4><ul>     <li>\n<b> Top Gainers, as of 5:15 p.m.:</b> GTI <font color=\"green\">+4.2%</font>. <a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a> <font color=\"green\">+3.3%</font>. <a href=\"https://seekingalpha.com/symbol/UVXY\" title=\"ProShares Ultra VIX Short-Term Futures ETF\">UVXY</a> <font color=\"green\">+2.6%</font>. <a href=\"https://seekingalpha.com/symbol/TSU\" title=\"TIM Participações S.A.\">TSU</a> <font color=\"green\">+2.3%</font>. <a href=\"https://seekingalpha.com/symbol/TVIX\" title=\"VelocityShares Daily 2x VIX Short-Term ETN\">TVIX</a> <font color=\"green\">+2.3%</font>.</li>\n<li>\n<b> Top Losers,</b><b><b>as of 5:15 p.m</b>:</b> <a href=\"https://seekingalpha.com/symbol/CTXS\" title=\"Citrix Systems, Inc.\">CTXS</a> <font color=\"red\">-14.0%</font>. <a href=\"https://seekingalpha.com/symbol/RT\" title=\"Ruby Tuesday, Inc.\">RT</a> <font color=\"red\">-13.2%</font>. <a href=\"https://seekingalpha.com/symbol/CKSW\" title=\"ClickSoftware Technologies Ltd.\">CKSW</a> <font color=\"red\">-11.2%</font>. <a href=\"https://seekingalpha.com/symbol/VOXX\" title=\"VOXX International Corp.\">VOXX</a> <font color=\"red\">-4.8%</font>. <a href=\"https://seekingalpha.com/symbol/HUBG\" title=\"Hub Group, Inc.\">HUBG</a> <font color=\"red\">-4.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1321592\" data-linked=\"After-hours Gainers / Losers\" data-tweet=\"$BAM $GILD $UVXY - After-hours Gainers / Losers https://seekingalpha.com/news/1321592-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1321592-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321522\" data-ts=\"1381352747\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321522-gilead-sciences-plus-3-percent-ah-on-strong-leukemia-drug-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilead Sciences +3% AH on strong leukemia drug data</a></h4><ul>     <li>Gilead Sciences (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a>) <font color=\"green\">+3%</font> AH after halting a Phase 3 study of a leukemia drug ahead of schedule because data showed it benefited patients.</li>     <li>The study evaluating idelalisib in previously-treated chronic lymphocytic leukemia patients not fit for chemotherapy will be stopped early based on an analysis showing highly statistically significant  efficacy for the primary endpoint of progression-free survival in patients receiving the drug plus rituximab compared to those receiving rituximab alone.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1321522\" data-linked=\"Gilead Sciences +3% AH on strong leukemia drug data\" data-tweet=\"$GILD - Gilead Sciences +3% AH on strong leukemia drug data https://seekingalpha.com/news/1321522-gilead-sciences-plus-3-percent-ah-on-strong-leukemia-drug-data?source=tweet\" data-url=\"https://seekingalpha.com/news/1321522-gilead-sciences-plus-3-percent-ah-on-strong-leukemia-drug-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321502\" data-ts=\"1381352246\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACUR\" target=\"_blank\">ACUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321502-acura-pharma-plus-12-percent-ah-on-oxecta-patent-litigation-settlement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acura Pharma +12% AH on Oxecta patent litigation settlement</a></h4><ul>     <li>Acura Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ACUR\" title=\"Acura Pharmaceuticals, Inc.\">OTC:ACUR</a>) <font color=\"green\">+11.8%</font> AH after announcing a settlement of patent litigation with Par Pharmaceutical (NYSE:<a href=\"https://seekingalpha.com/symbol/PRX\" title=\"Par Pharmaceutical Companies, Inc.\">PRX</a>) and Impax Labs (IPXL) over the pain drug Oxecta.</li>     <li>According to the terms, PRX may launch its generic Oxecta product in the U.S., through the grant of a non-exclusive license which requires it to pay ACUR royalties in the range of 10%-15% of PRX's net profits from the sale.</li>     <li>IPXL may launch its generic Oxecta product in the U.S. through the grant of a non-exclusive, royalty-free license.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1321502\" data-linked=\"Acura Pharma +12% AH on Oxecta patent litigation settlement\" data-tweet=\"$ACUR $ACUR $PRX - Acura Pharma +12% AH on Oxecta patent litigation settlement https://seekingalpha.com/news/1321502-acura-pharma-plus-12-percent-ah-on-oxecta-patent-litigation-settlement?source=tweet\" data-url=\"https://seekingalpha.com/news/1321502-acura-pharma-plus-12-percent-ah-on-oxecta-patent-litigation-settlement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321492\" data-ts=\"1381352221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CKSW\" target=\"_blank\">CKSW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321492-clicksoftware-issues-q3-warning-shares-minus-11_3-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ClickSoftware issues Q3 warning, shares -11.3% AH</a></h4><ul>\n<li>ClickSoftware (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CKSW\" title=\"ClickSoftware Technologies Ltd.\">CKSW</a>) now expects Q3 revenue of $23.2M and EPS of -$0.10, well below a consensus of $28.3M and $0.03. (PR)</li>\n<li>The workforce/field service software firm blames \"lower up-front license fees and a smaller initial deployment size,\" events that in turn are attributed to a transition to (subscription-based) cloud software sales. It adds cloud customers have doubled Y/Y over the first 9 months of 2013, and on-premise software customers have grown by 62%.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1284862\" target=\"_blank\">Adobe</a> and <a href=\"https://seekingalpha.com/currents/post/1310562\" target=\"_blank\">Autodesk</a> (among others) have also seen near-term sales hurt by a transition to cloud subscriptions, but the impact hasn't been as dramatic.</li>\n<li>Full Q3 results are due on Oct. 23.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1321492\" data-linked=\"ClickSoftware issues Q3 warning, shares -11.3% AH\" data-tweet=\"$CKSW - ClickSoftware issues Q3 warning, shares -11.3% AH https://seekingalpha.com/news/1321492-clicksoftware-issues-q3-warning-shares-minus-11_3-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1321492-clicksoftware-issues-q3-warning-shares-minus-11_3-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321482\" data-ts=\"1381351282\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATNY\" target=\"_blank\">ATNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321482-api-technologies-corp-eps-of-0_12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">API Technologies Corp EPS of $0.12</a></h4><ul>     <li>API Technologies Corp (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ATNY\" title=\"API Technologies\">ATNY</a>): FQ3 EPS of $0.12 may not be comparable to consensus of $-0.01.</li>     <li>Revenue of $62.6M .Shares  <font color=\"red\">-1.46%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1321482\" data-linked=\"API Technologies Corp EPS of $0.12\" data-tweet=\"$ATNY - API Technologies Corp EPS of $0.12 https://seekingalpha.com/news/1321482-api-technologies-corp-eps-of-0_12?source=tweet\" data-url=\"https://seekingalpha.com/news/1321482-api-technologies-corp-eps-of-0_12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321442\" data-ts=\"1381350396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTXS\" target=\"_blank\">CTXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321442-citrix-issues-q3-warning-enterprise-it-peers-fall-in-sympathy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citrix issues Q3 warning; enterprise IT peers fall in sympathy</a></h4><ul>     <li>Citrix (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CTXS\" title=\"Citrix Systems, Inc.\">CTXS</a>) expects Q3 revenue of $710M-$712M, below a prior guidance range of $730M-$740M and a $737.3M consensus. EPS guidance has been lowered to $0.68-$0.69, below a prior $0.72-$0.73 and a $0.73 consensus. (PR)</li>     <li>The thin client/virtualization software and application delivery controller vendor doesn't give a reason for the shortfall. Full Q3 results arrive on Oct. 23.</li>     <li>\n<a href=\"https://seekingalpha.com/symbol/CTXS\" title=\"Citrix Systems, Inc.\">CTXS</a> <font color=\"red\">-11.1%</font> AH. Off in sympathy: <a href=\"https://seekingalpha.com/symbol/RHT\" title=\"Red Hat, Inc.\">RHT</a> <font color=\"red\">-2.2%</font> <a href=\"https://seekingalpha.com/symbol/VMW\" title=\"VMware, Inc.\">VMW</a> <font color=\"red\">-4.4%</font>. EMC <font color=\"red\">-1.5%</font>. <a href=\"https://seekingalpha.com/symbol/FFIV\" title=\"F5 Networks, Inc.\">FFIV</a> <font color=\"red\">-4.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1321442\" data-linked=\"Citrix issues Q3 warning; enterprise IT peers fall in sympathy\" data-tweet=\"$CTXS $CTXS $RHT - Citrix issues Q3 warning; enterprise IT peers fall in sympathy https://seekingalpha.com/news/1321442-citrix-issues-q3-warning-enterprise-it-peers-fall-in-sympathy?source=tweet\" data-url=\"https://seekingalpha.com/news/1321442-citrix-issues-q3-warning-enterprise-it-peers-fall-in-sympathy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321422\" data-ts=\"1381350260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPL\" target=\"_blank\">BPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321422-buckeye-partners-buys-marine-terminals-for-850m-offers-6_5m-units\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buckeye Partners buys marine terminals for $850M, offers 6.5M units</a></h4><ul>     <li>Buckeye Partners (NYSE:<a href=\"https://seekingalpha.com/symbol/BPL\" title=\"Buckeye Partners L.P.\">BPL</a>) agrees to acquire 20 liquid petroleum products terminals with total storage capacity of ~39M barrels from Hess (NYSE:<a href=\"https://seekingalpha.com/symbol/HES\" title=\"Hess Corporation\">HES</a>) for $850M.</li>     <li>The 19 domestic terminals are located primarily in major metropolitan locations along the U.S. east coast with ~29M barrels of refined petroleum products storage capacity, including ~15M barrels of capacity strategically located in New York Harbor.</li>     <li>To fund the purchase, BPL commences a public offering of 6.5M units.</li>     <li>BPL <font color=\"red\">-2.3%</font> AH.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1321422\" data-linked=\"Buckeye Partners buys marine terminals for $850M, offers 6.5M units\" data-tweet=\"$BPL $BPL $HES - Buckeye Partners buys marine terminals for $850M, offers 6.5M units https://seekingalpha.com/news/1321422-buckeye-partners-buys-marine-terminals-for-850m-offers-6_5m-units?source=tweet\" data-url=\"https://seekingalpha.com/news/1321422-buckeye-partners-buys-marine-terminals-for-850m-offers-6_5m-units\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321412\" data-ts=\"1381350023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RT\" target=\"_blank\">RT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321412-tough-quarter-for-ruby-tuesday\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tough quarter for Ruby Tuesday</a></h4><ul>\n<li>Same-store sales fell 11.4% Y/Y at company-owned stores, and fell 8.4% at domestic Ruby Tuesday  franchise restaurants. Net loss from continuing operations of $21.9M vs. loss of $3.1M a year ago.</li>\n<li>\"The first quarter was challenging as the overall economy failed to realize any significant improvements which adversely affected us and the casual dining industry.\" Indeed.</li>\n<li>Fiscal 2014 outlook: Same-store sales expected to be down in the high single-digits in FQ2, with sequential improvement in FQ3 and FQ4.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1321392\" target=\"_blank\">FQ1 results</a>.</li>\n<li>\n<a href=\"http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.rubytuesday.com&amp;esheet=50725878&amp;newsitemid=20131009006327&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.rubytuesday.com&amp;index=1&amp;md5=88cc84755dfa1def5c6ae1f559a86954\" target=\"_blank\">Conference call</a> at 5 ET.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/RT\" title=\"Ruby Tuesday, Inc.\">RT</a> <font color=\"red\">-13%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1321412\" data-linked=\"Tough quarter for Ruby Tuesday\" data-tweet=\"$RT - Tough quarter for Ruby Tuesday https://seekingalpha.com/news/1321412-tough-quarter-for-ruby-tuesday?source=tweet\" data-url=\"https://seekingalpha.com/news/1321412-tough-quarter-for-ruby-tuesday\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321392\" data-ts=\"1381349373\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RT\" target=\"_blank\">RT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321392-ruby-tuesday-misses-by-0_32-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ruby Tuesday misses by $0.32, misses on revenue</a></h4><ul>     <li>Ruby Tuesday (NYSE:<a href=\"https://seekingalpha.com/symbol/RT\" title=\"Ruby Tuesday, Inc.\">RT</a>): FQ1 EPS of -$0.37 <font color=\"red\">misses by $0.32</font>.</li>\n<li>Revenue of $289.67M <font color=\"red\">misses by $8.93M</font>. Shares  <font color=\"red\">-10.88%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1321392\" data-linked=\"Ruby Tuesday misses by $0.32, misses on revenue\" data-tweet=\"$RT - Ruby Tuesday misses by $0.32, misses on revenue https://seekingalpha.com/news/1321392-ruby-tuesday-misses-by-0_32-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1321392-ruby-tuesday-misses-by-0_32-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321312\" data-ts=\"1381348560\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ULTR\" target=\"_blank\">ULTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321312-ultrapetrol-started-at-buy-at-stifel-citing-market-position-balance-sheet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ultrapetrol started at Buy at Stifel, citing market position, balance sheet</a></h4><ul>     <li>Ultrapetrol (<a href=\"https://seekingalpha.com/symbol/ULTR\" title=\"Ultrapetrol (Bahamas) Limited\">ULTR</a> <font color=\"green\">+4.9%</font>) is initiated with a <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/10/3978654/update-stifel-initiates-coverage-on-ultrapetrol-bahamas-\" target=\"_blank\">Buy rating</a> and $5 price target at Stifel Nicolaus, which calls the Bahamas-based industrial shipper a \"little company with big potential.\"</li>     <li>With record soy production driving river revenue and the contribution of additional vessels and higher day rates from the offshore oil field services segment, Stifel believes ULTR is likely to see EBITDA nearly triple from 2012 levels; the firm also thinks demand will continue to grow for river barges and offshore supply vessels in South America.</li>     <li>Given its view of ULTR's strong balance sheet, the firm believes the company is well positioned to fund  growth and see earnings and cash flows expand further.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1321312\" data-linked=\"Ultrapetrol started at Buy at Stifel, citing market position, balance sheet\" data-tweet=\"$ULTR - Ultrapetrol started at Buy at Stifel, citing market position, balance sheet https://seekingalpha.com/news/1321312-ultrapetrol-started-at-buy-at-stifel-citing-market-position-balance-sheet?source=tweet\" data-url=\"https://seekingalpha.com/news/1321312-ultrapetrol-started-at-buy-at-stifel-citing-market-position-balance-sheet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321292\" data-ts=\"1381347494\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARIA\" target=\"_blank\">ARIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321292-sell-side-rushes-to-cut-ratings-and-targets-on-ariad\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sell-side rushes to cut ratings and targets on Ariad</a></h4><ul>\n<li>William Blair <a href=\"http://finance.yahoo.com/news/ariad-price-target-lowered-7-174958667.html\" target=\"_blank\">lowers its price target</a> to $7 from $26 but <strong>retains its Buy rating</strong> as Ariad Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a> <font color=\"red\">-65.8%</font>) plummets following the FDA <a href=\"https://seekingalpha.com/currents/post/1320042\" target=\"_blank\">putting a partial clinical hold</a> on Iclusig and the company cutting worldwide peak sales estimates for the drug to $700M from $2B.</li>\n<li>Ariad CMO Frank Haluska: \"We anticipate that the clinical hold that the FDA has enacted will be temporary.\"</li>\n<li>Brean <a href=\"http://www.streetinsider.com/Analyst+Comments/Brean+Capital+Downgrades+ARIAD+Pharmaceuticals+%28ARIA%29+to+Hold/8764262.html\" target=\"_blank\">downgrades to Hold</a>: \"We are concerned about both the toxicity at 45mg and the efficacy at lower doses.\"</li>\n<li>BAML <a href=\"http://www.streetinsider.com/Downgrades/BofAMerrill+Lynch+Downgrades+ARIAD+Pharmaceuticals+%28ARIA%29+to+Neutral/8764390.html\" target=\"_blank\">removes its Buy</a> on the stock, now rating it a Hold.</li>\n<li>Stifel Nicolaus <a href=\"http://www.streetinsider.com/Downgrades/Stifel+Nicolaus+Downgrades+ARIAD+Pharmaceuticals+%28ARIA%29+to+Hold+-+Delayed/8763999.html\" target=\"_blank\">does the same</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1321292\" data-linked=\"Sell-side rushes to cut ratings and targets on Ariad\" data-tweet=\"$ARIA - Sell-side rushes to cut ratings and targets on Ariad https://seekingalpha.com/news/1321292-sell-side-rushes-to-cut-ratings-and-targets-on-ariad?source=tweet\" data-url=\"https://seekingalpha.com/news/1321292-sell-side-rushes-to-cut-ratings-and-targets-on-ariad\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321192\" data-ts=\"1381345096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCLN\" target=\"_blank\">OCLN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321192-originoil-signs-initial-deal-to-reuse-oil-field-water\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OriginOil signs initial deal to reuse oil field water</a></h4><ul>     <li>OriginOil (<a href=\"https://seekingalpha.com/symbol/OOIL\" title=\"Perkins Oil &amp; Gas Incorporated\">OTCPK:OOIL</a> <font color=\"red\">-7.5%</font>) signs its <a href=\"http://fuelfix.com/blog/2013/10/09/originoil-signs-deal-to-clean-oil-field-water-video/\" target=\"_blank\">first contract</a> to bring its water-cleansing technology to the oil field, for use in a process that will turn sludge from oil wells into water that can be reused.</li>     <li>The technology uses electrodes to create a reaction that forces sludge  to rise to the surface of a tank, then skims the  sludge off the top of the water, leaving it clean enough to be reused in fracking; the company will be paid on a per-barrel basis.</li>     <li>Shares are lower after agreeing to <a href=\"http://biz.yahoo.com/e/131009/ooil8-k.html\" target=\"_blank\">issue ~589K common shares</a> to \"consultants.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"1321192\" data-linked=\"OriginOil signs initial deal to reuse oil field water\" data-tweet=\"$OCLN $OCLN-OLD - OriginOil signs initial deal to reuse oil field water https://seekingalpha.com/news/1321192-originoil-signs-initial-deal-to-reuse-oil-field-water?source=tweet\" data-url=\"https://seekingalpha.com/news/1321192-originoil-signs-initial-deal-to-reuse-oil-field-water\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321162\" data-ts=\"1381343957\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AA\" target=\"_blank\">AA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321162-alcoa-up-big-after-solid-q3-but-analysts-arent-convinced\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcoa up big after solid Q3, but analysts aren&#39;t convinced</a></h4><ul>     <li>Alcoa's (<a href=\"https://seekingalpha.com/symbol/AA\" title=\"Alcoa Corporation\">AA</a> <font color=\"green\">+4.5%</font>) big gain after its <a href=\"https://seekingalpha.com/currents/post/1319412\" target=\"_blank\">Q3 results</a> beat expectations would have led the Dow Industrials, <a href=\"https://seekingalpha.com/currents/post/1270872\" target=\"_blank\">if it were still a member</a> of the Dow Industrials; analysts, however, <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/10/09/alcoa-to-the-dow-how-do-you-like-them-earnings\" target=\"_blank\">aren\u2019t jumping on the bandwagon</a>.</li>     <li>Cowen notes that Alcoa\u2019s beat was driven by cost cutting, enabling the company to offset the 3% Q/Q drop in realized aluminum prices.</li>\n<li>J.P. Morgan remains neutral on the stock, believing \"further efforts to reduce its costs in the upstream and grow the downstream will be hampered by a weak aluminum price environment over the next several years.\"</li>\n<li>The stock isn't particularly cheap, Barclays says; even with the strong Q3, AA is generating annualized EPS/EBITDA of $0.44/$2.7B, translating to a stock trading at 18x EPS and 7x EBITDA, with more downside potential than upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1321162\" data-linked=\"Alcoa up big after solid Q3, but analysts aren&#39;t convinced\" data-tweet=\"$AA - Alcoa up big after solid Q3, but analysts aren&#39;t convinced https://seekingalpha.com/news/1321162-alcoa-up-big-after-solid-q3-but-analysts-arent-convinced?source=tweet\" data-url=\"https://seekingalpha.com/news/1321162-alcoa-up-big-after-solid-q3-but-analysts-arent-convinced\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321092\" data-ts=\"1381342459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321092-stocks-reverse-big-early-losses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks reverse big early losses</a></h4><ul>\n<li>Markets have rebounded from sizable early losses with a rumored deal brewing between the Senate's Harry Reid and the House's John Boehner as good of an excuse as any to hit the buy button.</li>\n<li>The Dow (<a href=\"https://seekingalpha.com/symbol/dia\" title=\"SPDR Dow Jones Industrial Average ETF\">DIA</a> <font color=\"green\">+0.4%</font>) is up 60 and the Nasdaq 100 (<a href=\"https://seekingalpha.com/symbol/qqq\" title=\"PowerShares QQQ Trust ETF\">QQQ</a> <font color=\"red\">-0.2%</font>) has sliced into a loss of more than 1%.</li>\n<li>The <a href=\"https://seekingalpha.com/currents/post/1321062\" target=\"_blank\">FOMC minutes</a> suggest members felt the taper was still on the table as of three weeks ago, but plenty has transpired since, among them the government shutdown and the nomination of Janet Yellen as next Fed chief. The betting here says no taper until 2014 at the earliest.</li>\n<li>Dow and Nasdaq ETFs: <a href=\"https://seekingalpha.com/symbol/dia\" title=\"SPDR Dow Jones Industrial Average ETF\">DIA</a>, <a href=\"https://seekingalpha.com/symbol/ddm\" title=\"ProShares Ultra Dow 30 ETF\">DDM</a>, <a href=\"https://seekingalpha.com/symbol/udow\" title=\"ProShares UltraPro Dow 30 ETF\">UDOW</a>, <a href=\"https://seekingalpha.com/symbol/dxd\" title=\"ProShares UltraShort Dow30 ETF\">DXD</a>, <a href=\"https://seekingalpha.com/symbol/sdow\" title=\"ProShares UltraPro Short Dow 30 ETF\">SDOW</a>, <a href=\"https://seekingalpha.com/symbol/dog\" title=\"ProShares Short Dow 30 ETF\">DOG</a>, <a href=\"https://seekingalpha.com/symbol/qqq\" title=\"PowerShares QQQ Trust ETF\">QQQ</a>, <a href=\"https://seekingalpha.com/symbol/qqew\" title=\"First Trust NASDAQ-100 Equal Weight Index ETF\">QQEW</a>, <a href=\"https://seekingalpha.com/symbol/tqqq\" title=\"ProShares UltraPro QQQ ETF\">TQQQ</a>, <a href=\"https://seekingalpha.com/symbol/qid\" title=\"ProShares UltraShort QQQ ETF\">QID</a>, <a href=\"https://seekingalpha.com/symbol/sqqq\" title=\"ProShares UltraPro Short QQQ ETF\">SQQQ</a>, <a href=\"https://seekingalpha.com/symbol/psq\" title=\"ProShares Short QQQ ETF\">PSQ</a>, <a href=\"https://seekingalpha.com/symbol/qld\" title=\"ProShares Ultra QQQ ETF\">QLD</a>, <a href=\"https://seekingalpha.com/symbol/qqqe\" title=\"Direxion NASDAQ-100 Equal Weighted Index Shares ETF\">QQQE</a>.</li>\n<li>Treasury prices (<a href=\"https://seekingalpha.com/symbol/tlt\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a> <font color=\"red\">-0.7%</font>) remain a bit lower, the 10-year yield up 2 basis points to 2.66%.</li>\n<li>Treasury ETFs: <a href=\"https://seekingalpha.com/symbol/tlh\" title=\"iShares 10-20 Year Treasury Bond ETF\">TLH</a>, <a href=\"https://seekingalpha.com/symbol/tlt\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a>, <a href=\"https://seekingalpha.com/symbol/ief\" title=\"iShares 7-10 Year Treasury Bond ETF\">IEF</a>, <a href=\"https://seekingalpha.com/symbol/dtyl\" title=\"iPath U.S. Treasury 10-Year Bull ETN\">DTYL</a>, <a href=\"https://seekingalpha.com/symbol/dlbl\" title=\"iPath U.S. Treasury Long Bond Bull ETN\">DLBL</a>, <a href=\"https://seekingalpha.com/symbol/iltb\" title=\"iShares Core Long-Term U.S. Bond ETF\">ILTB</a>, <a href=\"https://seekingalpha.com/symbol/tenz\" title=\"PIMCO 7-15 Year U.S. Treasury Index ETF\">TENZ</a>, <a href=\"https://seekingalpha.com/symbol/ite\" title=\"SPDR Barclays Intermediate Term Treasury ETF\">ITE</a>, <a href=\"https://seekingalpha.com/symbol/tlo\" title=\"SPDR Barclays Long Term Treasury ETF\">TLO</a>, <a href=\"https://seekingalpha.com/symbol/edv\" title=\"Vanguard Extended Duration Treasury ETF\">EDV</a>, <a href=\"https://seekingalpha.com/symbol/vgit\" title=\"Vanguard Intermediate-Term Government Bond Index ETF\">VGIT</a>, <a href=\"https://seekingalpha.com/symbol/vglt\" title=\"Vanguard Long-Term Government Bond Index ETF\">VGLT</a>, <a href=\"https://seekingalpha.com/symbol/tmf\" title=\"Direxion Daily 30-Year Treasury Bull 3x Shares ETF\">TMF</a>, <a href=\"https://seekingalpha.com/symbol/tyd\" title=\"Direxion Daily 10-Year Treasury Bull 3x Shares ETF\">TYD</a>, <a href=\"https://seekingalpha.com/symbol/lbnd\" title=\"PowerShares DB 3x Long 25+ Year Treasury Bond ETN\">LBND</a>, <a href=\"https://seekingalpha.com/symbol/ubt\" title=\"ProShares Ultra 20+ Year Treasury ETF\">UBT</a>, <a href=\"https://seekingalpha.com/symbol/ust\" title=\"ProShares Ultra 7-10 Year Treasury ETF\">UST</a>, <a href=\"https://seekingalpha.com/symbol/tmv\" title=\"Direxion Daily 30-Year Treasury Bear 3x Shares ETF\">TMV</a>, <a href=\"https://seekingalpha.com/symbol/tyo\" title=\"Direxion Daily 10-Year Treasury Bear 3x Shares ETF\">TYO</a>, <a href=\"https://seekingalpha.com/symbol/sbnd\" title=\"PowerShares DB 3x Short 25+ Year Treasury Bond ETN\">SBND</a>, <a href=\"https://seekingalpha.com/symbol/pst\" title=\"ProShares UltraShort 7-10 Year Treasury ETF\">PST</a>, <a href=\"https://seekingalpha.com/symbol/tbt\" title=\"ProShares UltraShort 20+ Year Treasury ETF\">TBT</a>, <a href=\"https://seekingalpha.com/symbol/dtys\" title=\"iPath U.S. Treasury 10-Year Bear ETN\">DTYS</a>, <a href=\"https://seekingalpha.com/symbol/dlbs\" title=\"iPath U.S. Treasury Long Bond Bear ETN\">DLBS</a>, <a href=\"https://seekingalpha.com/symbol/tbf\" title=\"ProShares Short 20+ Year Treasury ETF\">TBF</a>, <a href=\"https://seekingalpha.com/symbol/ttt\" title=\"ProShares UltraPro Short 20+ Year Treasury ETF\">TTT</a>, <a href=\"https://seekingalpha.com/symbol/tyns\" title=\"Direxion Daily 7-10 Year Treasury Bear 1x ETF\">TYNS</a>, <a href=\"https://seekingalpha.com/symbol/tybs\" title=\"Direxion Daily 20+ Year Treasury Bear 1x ETF\">TYBS</a>, <a href=\"https://seekingalpha.com/symbol/tbx\" title=\"ProShares Short 7-10 Year Treasury ETF\">TBX</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1321092\" data-linked=\"Stocks reverse big early losses\" data-tweet=\"$DIA $QQQ $DDM - Stocks reverse big early losses https://seekingalpha.com/news/1321092-stocks-reverse-big-early-losses?source=tweet\" data-url=\"https://seekingalpha.com/news/1321092-stocks-reverse-big-early-losses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321072\" data-ts=\"1381342422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GDP\" target=\"_blank\">GDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321072-goodrich-minus-4-percent-on-mississippi-well-disappointment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goodrich -4% on Mississippi well disappointment</a></h4><ul>     <li>Goodrich Petroleum (<a href=\"https://seekingalpha.com/symbol/GDP\" title=\"Goodrich Petroleum Corp.\">GDP</a> <font color=\"red\">-3.9%</font>) slumps after saying it ran into \"completion issues\" which constrained initial production rates at its latest operated well in the Tuscaloosa Marine shale.</li>     <li>While the initial rate of 527 boe/day was well below GDP's prior pair of operated wells, MLV &amp; Co. says it compares favorably on a  per-stage basis; given the relative performance, the firm says today's stock selloff is overdone and it remains comfortable with its positive assumptions for the  Tuscaloosa Marine (Briefing.com).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1321072\" data-linked=\"Goodrich -4% on Mississippi well disappointment\" data-tweet=\"$GDP - Goodrich -4% on Mississippi well disappointment https://seekingalpha.com/news/1321072-goodrich-minus-4-percent-on-mississippi-well-disappointment?source=tweet\" data-url=\"https://seekingalpha.com/news/1321072-goodrich-minus-4-percent-on-mississippi-well-disappointment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321042\" data-ts=\"1381341357\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUR\" target=\"_blank\">CUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321042-neuralstem-rises-after-announcing-start-of-stem-cell-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neuralstem rises after announcing start of stem cell trial</a></h4><ul>\n<li>The University of Michigan has treated the first two patients in a Phase II trial testing the effectiveness of Neuralstem's (<a href=\"https://seekingalpha.com/symbol/CUR\" title=\"Neuralstem, Inc.\">CUR</a> <font color=\"green\">+5.9%</font>) NSI-566 neural stem cells in treating ALS (Lou Gehrig's disease). (PR)</li>\n<li>The trial is meant to treat 15 patients through a maximum of 40 injections. Today's news comes a month after Neuralstem announced Emory University, which is also taking part in the Phase II trial, had <a href=\"https://seekingalpha.com/currents/post/1270502\" target=\"_blank\">treated its first trial patient</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1321042\" data-linked=\"Neuralstem rises after announcing start of stem cell trial\" data-tweet=\"$CUR $SNCA - Neuralstem rises after announcing start of stem cell trial https://seekingalpha.com/news/1321042-neuralstem-rises-after-announcing-start-of-stem-cell-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/1321042-neuralstem-rises-after-announcing-start-of-stem-cell-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321012\" data-ts=\"1381339968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TI\" target=\"_blank\">TI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321012-telecom-italia-reportedly-wants-12_2b-for-brazilian-unit-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telecom Italia reportedly wants $12.2B for Brazilian unit stake</a></h4><ul><li><a href=\"http://www.bloomberg.com/news/2013-10-09/telecom-italia-is-said-to-seek-12-billion-for-brazil-stake.html\" target=\"_blank\">Bloomberg reports</a> Telecom Italia (<a href='https://seekingalpha.com/symbol/TI' title='Telecom Italia S.P.A.'>TI</a> <font color='green'>+7.5%</font>) is indeed trying to sell its 67% stake in Brazil's TIM Participacoes (<a href='https://seekingalpha.com/symbol/TSU' title='TIM Participações S.A.'>TSU</a> <font color='green'>+6.6%</font>), and wants at least &euro;9B ($12.2B) for it. TI's efforts are said to be in their early stages; no banks have been hired yet.</li><li>TI and TIM are rallying, and so is Telefonica (<a href='https://seekingalpha.com/symbol/TEF' title='Telefonica S.A.'>TEF</a> <font color='green'>+1.9%</font>), which is <a href=\"https://seekingalpha.com/currents/post/1297032\" target=\"_blank\">set to own 22.4%</a> of TI and has been pushing for a TIM sale.</li><li>The report comes a day after <a href=\"https://seekingalpha.com/currents/post/1319562\" target=\"_blank\">Moody's cut</a> TI's senior debt rating to junk; selling TIM would do much to shore up TI's balance sheet.</li></ul><div class=\"tiny-share-widget\" data-id=\"1321012\" data-linked=\"Telecom Italia reportedly wants $12.2B for Brazilian unit stake\" data-tweet=\"$TI $TI $TSU - Telecom Italia reportedly wants $12.2B for Brazilian unit stake https://seekingalpha.com/news/1321012-telecom-italia-reportedly-wants-12_2b-for-brazilian-unit-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/1321012-telecom-italia-reportedly-wants-12_2b-for-brazilian-unit-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1321002\" data-ts=\"1381339283\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JASO\" target=\"_blank\">JASO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1321002-its-solars-turn-to-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">It&#39;s solar&#39;s turn to fall</a></h4><ul>\n<li>A day after Internet stocks with big 2013 gains <a href=\"https://seekingalpha.com/currents/post/1318782\" target=\"_blank\">tumbled</a> as part of a general rout in risk assets, solar stocks are largely doing the same (<a href=\"https://seekingalpha.com/symbol/TAN\" title=\"Invesco Solar Portfolio ETF\">TAN</a> <font color=\"red\">-3.2%</font>).</li>\n<li>Notable decliners include JA Solar (<a href=\"https://seekingalpha.com/symbol/JASO\" title=\"JA Solar Holdings, Co., Ltd.\">JASO</a> <font color=\"red\">-6.5%</font>), JinkoSolar (<a href=\"https://seekingalpha.com/symbol/JKS\" title=\"JinkoSolar Holding Co., Ltd.\">JKS</a> <font color=\"red\">-5.6%</font>), First Solar (<a href=\"https://seekingalpha.com/symbol/FSLR\" title=\"First Solar, Inc.\">FSLR</a> <font color=\"red\">-2%</font>), SunPower (<a href=\"https://seekingalpha.com/symbol/SPWR\" title=\"SunPower Corporation\">SPWR</a> <font color=\"red\">-2.2%</font>), ReneSola (<a href=\"https://seekingalpha.com/symbol/SOL\" title=\"ReneSola Ltd.\">SOL</a> <font color=\"red\">-3.7%</font>), Yingli (<a href=\"https://seekingalpha.com/symbol/YGE\" title=\"Yingli Green Energy Holding Company Limited\">YGE</a> <font color=\"red\">-3.9%</font>), Trina (<a href=\"https://seekingalpha.com/symbol/TSL\" title=\"Trina Solar Limited\">TSL</a> <font color=\"red\">-2.2%</font>), SunEdison (SUNE <font color=\"red\">-0.4%</font>), and Canadian Solar (<a href=\"https://seekingalpha.com/symbol/CSIQ\" title=\"Canadian Solar Inc.\">CSIQ</a> <font color=\"red\">-4.6%</font>).</li>\n<li>SolarCity (SCTY <font color=\"red\">-4.7%</font>) is following peers lower on a day when it announced the <a href=\"https://seekingalpha.com/currents/post/1320172\" target=\"_blank\">$158M acquisition</a> of mounting systems supplier Zep Solar. Shares outperformed yesterday following <a href=\"https://seekingalpha.com/currents/post/1319612\" target=\"_blank\">the singing</a> of a California solar bill.</li>\n<li>Suntech (<a href=\"https://seekingalpha.com/symbol/STP\" title=\"Suntech Power Holdings Co., Ltd.\">STP</a> <font color=\"red\">-3.5%</font>) has given up the premarket gains it saw on news two Chinese solar cell makers <a href=\"https://seekingalpha.com/currents/post/1320062\" target=\"_blank\">have made bids</a> for the company.</li>\n<li>Debt-laden LDK (<a href=\"https://seekingalpha.com/symbol/LDK\" title=\"LDK Solar Co., Ltd.\">LDK</a> <font color=\"green\">+4.6%</font>), which <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1380916800000&amp;chddm=74715&amp;chls=IntervalBasedLine&amp;q=NYSE:LDK&amp;ntsp=1&amp;ei=XJBVUrDdL8OgiAKCpAE\" target=\"_blank\">has missed out</a> on this year's big solar rally, is bucking the trend.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1321002\" data-linked=\"It&#39;s solar&#39;s turn to fall\" data-tweet=\"$JASO $TAN $JASO - It&#39;s solar&#39;s turn to fall https://seekingalpha.com/news/1321002-its-solars-turn-to-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/1321002-its-solars-turn-to-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320962\" data-ts=\"1381338170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LKM\" target=\"_blank\">LKM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320962-nq-mobile-sells-off-after-pricing-150m-convertible-debt-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NQ Mobile sells off after pricing $150M convertible debt offering</a></h4><ul>     <li>NQ's (NQ <font color=\"red\">-6.2%</font>) convertible notes are due Oct. 15, 2018, have an interest rate of 4%, and feature a conversion price of $25.61 (39% above where shares currently trade). (PR)</li>     <li>NQ is now <font color=\"red\">down 12%</font> since first <a href=\"https://seekingalpha.com/currents/post/1317472\" target=\"_blank\">announcing the offering</a> on Monday afternoon, thanks in part to <a href=\"https://seekingalpha.com/currents/post/1318782\" target=\"_blank\">a broader selloff</a> in Internet/momentum stocks.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1320962\" data-linked=\"NQ Mobile sells off after pricing $150M convertible debt offering\" data-tweet=\"$LKM - NQ Mobile sells off after pricing $150M convertible debt offering https://seekingalpha.com/news/1320962-nq-mobile-sells-off-after-pricing-150m-convertible-debt-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1320962-nq-mobile-sells-off-after-pricing-150m-convertible-debt-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320912\" data-ts=\"1381337188\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320912-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Top 10 Gainers:</b> <a href=\"https://seekingalpha.com/symbol/OINK\" title=\"Tianli Agritech, Inc.\">OINK</a> <font color=\"green\">+37%</font>. MW <font color=\"green\">+29%</font>. <a href=\"https://seekingalpha.com/symbol/VISN\" title=\"VisionChina Media, Inc.\">VISN</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/ALTI\" title=\"Altair Nanotechnologies Inc.\">ALTI</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/KUTV\" title=\"Ku6 Media Co., Ltd.\">KUTV</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/CERE\" title=\"Ceres, Inc.\">CERE</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/CALD\" title=\"Callidus Software, Inc.\">CALD</a> <font color=\"green\">+14%</font>. URRE <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/MG\" title=\"MISTRAS Group, Inc.\">MG</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/ICAD\" title=\"iCAD, Inc.\">ICAD</a> <font color=\"green\">+10%</font>.</li>\n<li>\n<b>Top 10 Losers:</b> <a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a> <font color=\"red\">-70%</font>. <a href=\"https://seekingalpha.com/symbol/LRN\" title=\"K12 Inc.\">LRN</a> <font color=\"red\">-37%</font>. <a href=\"https://seekingalpha.com/symbol/PVG\" title=\"Pretium Resources Inc\">PVG</a> <font color=\"red\">-26%</font>. <a href=\"https://seekingalpha.com/symbol/CYTR\" title=\"CytRx Corporation\">CYTR</a> <font color=\"red\">-20%</font>. LPTN <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/LAS\" title=\"Lentuo International Inc.\">LAS</a> <font color=\"red\">-18%</font>. <a href=\"https://seekingalpha.com/symbol/FATE\" title=\"Fate Therapeutics, Inc.\">FATE</a> <font color=\"red\">-18%</font>. <a href=\"https://seekingalpha.com/symbol/PBYI\" title=\"Puma Biotechnology, Inc.\">PBYI</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/ATOS\" title=\"Atossa Genetics, Inc.\">ATOS</a> <font color=\"red\">-14%</font>. OPXA <font color=\"red\">-13%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1320912\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$OINK $TLRD $VISN - Midday Gainers / Losers https://seekingalpha.com/news/1320912-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1320912-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320862\" data-ts=\"1381335916\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320862-sarepta-hit-by-new-short-attack-general-biotech-selloff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta hit by new short attack; general biotech selloff</a></h4><ul>\n<li>Clinical trial data for eteplirsen<a href=\"http://www.streetinsider.com/Momentum+Movers/Sarepta+Therapeutics+%28SRPT%29+Falls+on+New+Short+Report/8763764.html\" target=\"_blank\"> not enough</a> for early/accelerated FDA approval is among the claims of research shop Favus in what Adam Feuerstein calls a \"rehash of old short arguments.\"</li>\n<li>Sarepta Therapeutics (<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a> <font color=\"red\">-8.4%</font>).</li>\n<li>Not helping is a second straight day of big declines for momentum names in general and <a href=\"https://seekingalpha.com/currents/post/1320612\" target=\"_blank\">biotech stocks in particular</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1320862\" data-linked=\"Sarepta hit by new short attack; general biotech selloff\" data-tweet=\"$SRPT - Sarepta hit by new short attack; general biotech selloff https://seekingalpha.com/news/1320862-sarepta-hit-by-new-short-attack-general-biotech-selloff?source=tweet\" data-url=\"https://seekingalpha.com/news/1320862-sarepta-hit-by-new-short-attack-general-biotech-selloff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320852\" data-ts=\"1381335657\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPQ\" target=\"_blank\">HPQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320852-h-p-jumps-following-analyst-day-remarks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">H-P jumps following analyst day remarks</a></h4><ul>\n<li>During H-P's (<a href=\"https://seekingalpha.com/symbol/HPQ\" title=\"HP Inc.\">HPQ</a> <font color=\"green\">+5.7%</font>) 2013 analyst day, Meg Whitman predicts the IT giant's revenue will \"stabilize\" in FY14 (ends Oct. '14), and start growing again in FY15. H-P is <a href=\"http://finance.yahoo.com/q/ae?s=HPQ+Analyst+Estimates\" target=\"_blank\">currently expected</a> to see a 3.1% FY14 revenue drop, following a 7.7% drop for FY13. (<a href=\"http://allthingsd.com/20131009/liveblogging-hps-2013-securities-analyst-meeting/?mod=atdtweet\" target=\"_blank\">live blog</a>) (<a href=\"http://ctt.marketwire.com/?release=1053931&amp;id=3471739&amp;type=1&amp;url=http%3a%2f%2fwww.hp.com%2finvestor%2fSAM2013\" target=\"_blank\">webcast</a>)</li>\n<li>Whitman also declares H-P has stabilized its <a href=\"https://seekingalpha.com/currents/post/1236542\" target=\"_blank\">struggling</a> enterprise services ops, and the the company's net debt is now below pre-Autonomy levels. No additional restructuring is planned; last year, H-P announced one featuring <a href=\"https://seekingalpha.com/currents/post/529811\" target=\"_blank\">29K job cuts</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1320852\" data-linked=\"H-P jumps following analyst day remarks\" data-tweet=\"$HPQ - H-P jumps following analyst day remarks https://seekingalpha.com/news/1320852-h-p-jumps-following-analyst-day-remarks?source=tweet\" data-url=\"https://seekingalpha.com/news/1320852-h-p-jumps-following-analyst-day-remarks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320842\" data-ts=\"1381335575\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TK\" target=\"_blank\">TK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320842-teekay-shipping-plus-2_2-percent-after-barclays-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teekay Shipping +2.2% after Barclays upgrade</a></h4><ul>     <li>Teekay Shipping (<a href=\"https://seekingalpha.com/symbol/TK\" title=\"Teekay Corporation\">TK</a> <font color=\"green\">+2.2%</font>) is <a href=\"http://www.streetinsider.com/Upgrades/Barclays+Upgrades+Teekay+Corp.+%28TK%29+to+Overweight/8762420.html\" target=\"_blank\">upgraded</a> to Overweight from Equal Weight with a new $56 price target, up from $35, at Barclays, which believes higher cash distributions from general partnership interests along with lower leverage from transitioning to an asset-light marine transportation manager are creating a positive inflection point for shareholders.</li>     <li>Given this backdrop, the firm believes shareholder distributions could nearly double by 2016, creating a  compelling investment case.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1320842\" data-linked=\"Teekay Shipping +2.2% after Barclays upgrade\" data-tweet=\"$TK - Teekay Shipping +2.2% after Barclays upgrade https://seekingalpha.com/news/1320842-teekay-shipping-plus-2_2-percent-after-barclays-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1320842-teekay-shipping-plus-2_2-percent-after-barclays-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320802\" data-ts=\"1381334438\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADTN\" target=\"_blank\">ADTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320802-adtran-plunges-on-soft-q4-guidance-peers-also-selling-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adtran plunges on soft Q4 guidance; peers also selling off</a></h4><ul>     <li>Adtran (<a href=\"https://seekingalpha.com/symbol/ADTN\" title=\"ADTRAN, Inc.\">ADTN</a> <font color=\"red\">-13.3%</font>) <a href=\"https://twitter.com/financialjuice/status/387952333243826177\" target=\"_blank\">guides</a> on its Q3 CC for Q4 revenue to drop by a high single-digit to low-teen percentage Q/Q; that's worse than a consensus for a 7% decline.</li>     <li>Shares have nosedived on the guidance after trading higher earlier today in response to the telecom equipment vendor's <a href=\"https://seekingalpha.com/currents/post/1319812\" target=\"_blank\">Q3 beat</a>.</li>     <li>Several other telecom equipment firms are also seeing sizable declines on a down day for tech, as are some component/chip suppliers. <a href=\"https://seekingalpha.com/symbol/CIEN\" title=\"Ciena Corporation\">CIEN</a> <font color=\"red\">-4.3%</font>. JDSU <font color=\"red\">-3.9%</font>. <a href=\"https://seekingalpha.com/symbol/FNSR\" title=\"Finisar Corporation\">FNSR</a> <font color=\"red\">-4.5%</font>. <a href=\"https://seekingalpha.com/symbol/JNPR\" title=\"Juniper Networks\">JNPR</a> <font color=\"red\">-2.8%</font>. <a href=\"https://seekingalpha.com/symbol/AMCC\" title=\"Applied Micro Circuits Corporation\">AMCC</a> <font color=\"red\">-3.8%</font>. <a href=\"https://seekingalpha.com/symbol/DRWI\" title=\"DragonWave Inc.\">DRWI</a> <font color=\"red\">-4.7%</font>. <a href=\"https://seekingalpha.com/symbol/RVBD\" title=\"Riverbed Technology, Inc.\">RVBD</a> <font color=\"red\">-3.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1320802\" data-linked=\"Adtran plunges on soft Q4 guidance; peers also selling off\" data-tweet=\"$ADTN $ADTN $CIEN - Adtran plunges on soft Q4 guidance; peers also selling off https://seekingalpha.com/news/1320802-adtran-plunges-on-soft-q4-guidance-peers-also-selling-off?source=tweet\" data-url=\"https://seekingalpha.com/news/1320802-adtran-plunges-on-soft-q4-guidance-peers-also-selling-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320792\" data-ts=\"1381334333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VWDRY\" target=\"_blank\">VWDRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320792-vestas-sells-manufacturing-units-for-1-shares-slide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vestas sells manufacturing units for \u20ac1, shares slide</a></h4><ul>     <li>Shares in Danish wind turbine maker Vestas (<a href='https://seekingalpha.com/symbol/VWDRY' title='Vestas Wind Systems A/S ADR'>OTCPK:VWDRY</a> <font color='red'>-3.9%</font>) tumble as investors reflect their disappointment at the <a href=\"http://www.ft.com/intl/cms/s/0/6434f914-30df-11e3-b478-00144feab7de.html#axzz2hDvkdbXZ\" target=\"_blank\">sale of six manufacturing units for just &euro;1</a>, implying a writedown of &euro;50M on the assets.</li>     <li><div>Vestas says it made the sale \"because we operate in a volatile market with steep ups and  downs, and we realised that fixed costs were too high, so we needed to  outsource non-core activities and focus on core competencies.\"</div></li> </ul><div class=\"tiny-share-widget\" data-id=\"1320792\" data-linked=\"Vestas sells manufacturing units for \u20ac1, shares slide\" data-tweet=\"$VWDRY - Vestas sells manufacturing units for \u20ac1, shares slide https://seekingalpha.com/news/1320792-vestas-sells-manufacturing-units-for-1-shares-slide?source=tweet\" data-url=\"https://seekingalpha.com/news/1320792-vestas-sells-manufacturing-units-for-1-shares-slide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320662\" data-ts=\"1381331342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XONE\" target=\"_blank\">XONE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320662-exone-higher-following-janney-coverage-launch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ExOne higher following Janney coverage launch</a></h4><ul><li>Janney has launched coverage on ExOne (<a href='https://seekingalpha.com/symbol/XONE' title='ExOne'>XONE</a> <font color='green'>+2.7%</font>) with a Buy and $70 PT.</li><li>Shares <a href=\"https://seekingalpha.com/currents/post/1317062\" target=\"_blank\">rose on Monday</a> after FBR passed on upbeat comments heard during talks with management.</li></ul><div class=\"tiny-share-widget\" data-id=\"1320662\" data-linked=\"ExOne higher following Janney coverage launch\" data-tweet=\"$XONE - ExOne higher following Janney coverage launch https://seekingalpha.com/news/1320662-exone-higher-following-janney-coverage-launch?source=tweet\" data-url=\"https://seekingalpha.com/news/1320662-exone-higher-following-janney-coverage-launch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320612\" data-ts=\"1381330355\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320612-catalyst-pharmaceuticals-tumbles-ahead-of-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharmaceuticals tumbles ahead of presentation</a></h4><ul>\n<li>Catalyst Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/CPRX\" title=\"Catalyst Pharmaceuticals, Inc.\">CPRX</a> <font color=\"red\">-8.2%</font>) is sharply lower amid the release of <a href=\"http://files.shareholder.com/downloads/CPRX/2724411676x0x695249/c72339a1-a9cb-4163-9588-b565c3959149/CPRX131008.pdf\" target=\"_blank\">presentation slides</a> ahead of the company's appearance at 12 ET at the BIO Investor Forum.</li>\n<li>The formerly high-flying biotech sector in general is having another tough day.</li>\n<li>ETFs: BBH (<a href=\"https://seekingalpha.com/symbol/BBH\" title=\"VanEck Vectors Biotech ETF\">BBH</a> <font color=\"red\">-3.4%</font>), IBB (<a href=\"https://seekingalpha.com/symbol/IBB\" title=\"iShares Nasdaq Biotechnology ETF\">IBB</a> <font color=\"red\">-2.9%</font>), XBI (<a href=\"https://seekingalpha.com/symbol/XBI\" title=\"SPDR Biotech ETF\">XBI</a> <font color=\"red\">-4.9%</font>).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1320612\" data-linked=\"Catalyst Pharmaceuticals tumbles ahead of presentation\" data-tweet=\"$CPRX $CPRX $BBH - Catalyst Pharmaceuticals tumbles ahead of presentation https://seekingalpha.com/news/1320612-catalyst-pharmaceuticals-tumbles-ahead-of-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/1320612-catalyst-pharmaceuticals-tumbles-ahead-of-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320592\" data-ts=\"1381329658\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVG\" target=\"_blank\">PVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320592-pretium-resources-minus-31-percent-after-resignation-of-bulk-sample-overseer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pretium Resources -31% after resignation of bulk sample overseer</a></h4><ul>     <li>Pretium Resources (<a href=\"https://seekingalpha.com/symbol/PVG\" title=\"Pretium Resources Inc\">PVG</a> <font color=\"red\">-31.6%</font>) plunges on news that Strathcona Mineral Services, which had been engaged to oversee and report on the bulk sample program for the Valley of the Kings at the miner's Brucejack project in British Columbia, has <a href=\"http://finance.yahoo.com/news/pretium-resources-inc-bulk-sample-110000276.html\" target=\"_blank\">resigned</a>; the company offers no explanation.</li>     <li>The processing of the excavated 10K metric tons is proceeding as planned at a rate of ~1K/week to produce gold/silver gravity and flotation concentrates.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1320592\" data-linked=\"Pretium Resources -31% after resignation of bulk sample overseer\" data-tweet=\"$PVG - Pretium Resources -31% after resignation of bulk sample overseer https://seekingalpha.com/news/1320592-pretium-resources-minus-31-percent-after-resignation-of-bulk-sample-overseer?source=tweet\" data-url=\"https://seekingalpha.com/news/1320592-pretium-resources-minus-31-percent-after-resignation-of-bulk-sample-overseer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320572\" data-ts=\"1381329479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GMCR\" target=\"_blank\">GMCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320572-green-mountain-coffee-roasters-down-after-k-cup-data-released\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Green Mountain Coffee Roasters down after K-cup data released</a></h4><ul> <li>Shares of Green Mountain Coffee Roasters (<a href='https://seekingalpha.com/symbol/GMCR' title='Keurig Green Mountain Inc'>GMCR</a> <font color='red'>-5.7%</font>) shoot lower after data indicates the K-cup category showed decelerating growth.</li> <li>Nielson reportedly <a href=\"https://twitter.com/firstadopter/status/387940796588371970\" target=\"_blank\">shows</a> 35% Y/Y growth for K-cup compared to 40.7% in August.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1320572\" data-linked=\"Green Mountain Coffee Roasters down after K-cup data released\" data-tweet=\"$GMCR - Green Mountain Coffee Roasters down after K-cup data released https://seekingalpha.com/news/1320572-green-mountain-coffee-roasters-down-after-k-cup-data-released?source=tweet\" data-url=\"https://seekingalpha.com/news/1320572-green-mountain-coffee-roasters-down-after-k-cup-data-released\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320472\" data-ts=\"1381326718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320472-j-c-penney-higher-after-board-change\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.C. Penney higher after board change</a></h4><ul> <li>J.C. Penney (<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a> <font color='green'>+1.3%</font>) moves higher after the retailer <a href=\"https://seekingalpha.com/currents/post/1320032\" target=\"_blank\">announces</a> Saks CEO Stephen Sandove will be joining its board of directors soon.</li> <li>Analysts see the move as a positive sign after Sandove led Saks to a lucrative buyout earlier this year.</li> <li>The exec may carry the clout to make <a href=\"https://twitter.com/BrianSozzi/status/387935939852382209\" target=\"_blank\">sweeping changes</a> with management, notes Belus Capital's Brian Sozzi.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1320472\" data-linked=\"J.C. Penney higher after board change\" data-tweet=\"$JCP - J.C. Penney higher after board change https://seekingalpha.com/news/1320472-j-c-penney-higher-after-board-change?source=tweet\" data-url=\"https://seekingalpha.com/news/1320472-j-c-penney-higher-after-board-change\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320392\" data-ts=\"1381324714\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320392-blackberry-settles-with-wilan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry settles with WiLAN</a></h4><ul>     <li>A day after announcing it has <a href=\"https://seekingalpha.com/currents/post/1318422\" target=\"_blank\">settled a patent dispute</a> with mobile messaging startup Kik, BlackBerry (BBRY) says it has settled all outstanding disputes with WiLAN (WILN). (PR)</li>     <li>BlackBerry has \"obtained a license to certain patents\" asserted by WiLAN in a <a href=\"https://seekingalpha.com/currents/post/712901\" target=\"_blank\">Florida suit</a>, and the companies will \"pursue licensing discussions regarding certain other wireless technologies.\"</li>     <li>WILN <font color=\"green\">+4%</font> premarket. Shares jumped last month after the company announced a <a href=\"https://seekingalpha.com/currents/post/1286782\" target=\"_blank\">licensing deal with HTC</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1320392\" data-linked=\"BlackBerry settles with WiLAN\" data-tweet=\"$BB $BB $QTRH - BlackBerry settles with WiLAN https://seekingalpha.com/news/1320392-blackberry-settles-with-wilan?source=tweet\" data-url=\"https://seekingalpha.com/news/1320392-blackberry-settles-with-wilan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320362\" data-ts=\"1381324338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320362-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul>\n<li>\n<b>Gainers:</b> MW <font color=\"green\">+24%</font>. <a href=\"https://seekingalpha.com/symbol/CPRX\" title=\"Catalyst Pharmaceuticals, Inc.\">CPRX</a> <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/JOSB\" title=\"Jos. A. Bank Clothiers, Inc.\">JOSB</a> <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/XONE\" title=\"ExOne\">XONE</a> <font color=\"green\">+5%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a> <font color=\"red\">-66%</font>. <a href=\"https://seekingalpha.com/symbol/LRN\" title=\"K12 Inc.\">LRN</a> <font color=\"red\">-25%</font>. <a href=\"https://seekingalpha.com/symbol/CYTR\" title=\"CytRx Corporation\">CYTR</a> <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/PVG\" title=\"Pretium Resources Inc\">PVG</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/VISN\" title=\"VisionChina Media, Inc.\">VISN</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/YUM\" title=\"Yum! Brands, Inc.\">YUM</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/TWGP\" title=\"Tower Group, Inc.\">TWGP</a> <font color=\"red\">-5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1320362\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$TLRD $CPRX $JOSB - Premarket Gainers / Losers https://seekingalpha.com/news/1320362-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1320362-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320342\" data-ts=\"1381324227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRD\" target=\"_blank\">TLRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320342-the-mens-wearhouse-says-no-to-jos-a-bank-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Men&#39;s Wearhouse says no to Jos. A Bank offer</a></h4><ul> <li>The Men's Wearhouse (MW) rejects the $48-per-share offer from Jos. A Bank (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JOSB\" title=\"Jos. A. Bank Clothiers, Inc.\">JOSB</a>) after concluding it significantly undervalued the company.</li> <li>Premarket: JOSB <font color=\"green\">+6.1%</font>, MW <font color=\"green\">+25.7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1320342\" data-linked=\"The Men&#39;s Wearhouse says no to Jos. A Bank offer\" data-tweet=\"$TLRD $TLRD $JOSB - The Men&#39;s Wearhouse says no to Jos. A Bank offer https://seekingalpha.com/news/1320342-the-mens-wearhouse-says-no-to-jos-a-bank-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/1320342-the-mens-wearhouse-says-no-to-jos-a-bank-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320302\" data-ts=\"1381323154\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTR\" target=\"_blank\">CYTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320302-cytrx-slumps-further-after-pricing-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CytRx slumps further after pricing offering</a></h4><ul> <li>CytRx (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CYTR\" title=\"CytRx Corporation\">CYTR</a>) prices its 10M share offering at $2.25 per share.</li> <li>CYTR <font color=\"red\">-18.4%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1320302\" data-linked=\"CytRx slumps further after pricing offering\" data-tweet=\"$CYTR - CytRx slumps further after pricing offering https://seekingalpha.com/news/1320302-cytrx-slumps-further-after-pricing-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1320302-cytrx-slumps-further-after-pricing-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320252\" data-ts=\"1381322564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FAST\" target=\"_blank\">FAST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320252-fastenal-minus-5-percent-premarket-after-q3-falls-short-of-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fastenal -5% premarket after Q3 falls short of estimates</a></h4><ul>     <li>More on Fastenal's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FAST\" title=\"Fastenal Company\">FAST</a>) <a href=\"https://seekingalpha.com/currents/post/1319832\" target=\"_blank\">Q3 results</a>: As in its Q2 report, FAST warns that sales  growth was held back in part by global economic uncertainty and economic  policy uncertainty in the U.S.</li>     <li>Sales rose 7% to $858M but were aided in part by an additional business day versus last year's quarter; gross margin edged up to 51.7% from 51.6%.</li>     <li>FAST had 2,686 stores as of Sept. 30, up 1.4% Y/Y.</li>     <li>Prospects for stronger demand <a href=\"http://www.nasdaq.com/article/fastenal-3rd-quarter-net-up-92-on-higher-sales-20131009-00192\" target=\"_blank\">look dim for now</a>, as William Blair analysts said this week the industrial and non-residential construction markets lack sustained momentum with no material pickup in  non-residential construction until 2014.</li>     <li>Shares <font color=\"red\">-4.9%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1320252\" data-linked=\"Fastenal -5% premarket after Q3 falls short of estimates\" data-tweet=\"$FAST - Fastenal -5% premarket after Q3 falls short of estimates https://seekingalpha.com/news/1320252-fastenal-minus-5-percent-premarket-after-q3-falls-short-of-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/1320252-fastenal-minus-5-percent-premarket-after-q3-falls-short-of-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320212\" data-ts=\"1381321701\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGEN\" target=\"_blank\">CGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320212-compugen-drug-effective-vs-type-i-diabetes-animal-model\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Compugen drug effective vs. type I diabetes animal model</a></h4><ul>     <li>Compugen (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CGEN\" title=\"Compugen Ltd.\">CGEN</a>) <font color=\"green\">+4.8%</font> premarket after announcing a study of its CGEN-15001 Fc fusion protein drug candidate demonstrated high effectiveness in an animal model of autoimmune type I diabetes.</li>     <li>The study suggests the drug turns off the autoimmune process and may potentially lead to restoration of immune tolerance and resolution of autoimmunity, arresting disease progression.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1320212\" data-linked=\"Compugen drug effective vs. type I diabetes animal model\" data-tweet=\"$CGEN - Compugen drug effective vs. type I diabetes animal model https://seekingalpha.com/news/1320212-compugen-drug-effective-vs-type-i-diabetes-animal-model?source=tweet\" data-url=\"https://seekingalpha.com/news/1320212-compugen-drug-effective-vs-type-i-diabetes-animal-model\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320202\" data-ts=\"1381321587\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGIX\" target=\"_blank\">CGIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320202-two-shelf-offerings-in-healthcare-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Two shelf offerings in healthcare sector</a></h4><ul>\n<li>Diagnostic firm Cancer Genetics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CGIX\" title=\"Cancer Genetics, Inc.\">CGIX</a>) files <a href=\"http://www.sec.gov/Archives/edgar/data/1349929/000119312513394340/d605621ds1.htm\" target=\"_blank\">a $46M shelf offering</a> of common stock, while biotech Portola Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PTLA\" title=\"Portola Pharmaceuticals\">PTLA</a>) files <a href=\"http://www.sec.gov/Archives/edgar/data/1269021/000119312513393061/d601496ds1.htm\" target=\"_blank\">a $100M shelf</a>.</li>\n<li>CGIX <font color=\"red\">-5.6%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1320202\" data-linked=\"Two shelf offerings in healthcare sector\" data-tweet=\"$CGIX $CGIX $PTLA - Two shelf offerings in healthcare sector https://seekingalpha.com/news/1320202-two-shelf-offerings-in-healthcare-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/1320202-two-shelf-offerings-in-healthcare-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320152\" data-ts=\"1381320309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRN\" target=\"_blank\">LRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320152-k12-crumbles-after-enrollment-shocker-peers-on-watch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">K12 crumbles after enrollment shocker, peers on watch</a></h4><ul> <li>The for-profit education sector could see some action today after K12 reported enrollment figures below expectations and received several harsh downgrades due to the low demand the company expects.</li> <li>In premarket trading, K12 (NYSE:<a href=\"https://seekingalpha.com/symbol/LRN\" title=\"K12 Inc.\">LRN</a>) has cratered and is <font color=\"red\">down 23.4%</font>.</li> <li>On watch: <a href=\"https://seekingalpha.com/symbol/CECO\" title=\"Career Education Corporation\">CECO</a>, <a href=\"https://seekingalpha.com/symbol/APOL\" title=\"Apollo Education Group, Inc.\">APOL</a>, <a href=\"https://seekingalpha.com/symbol/STRA\" title=\"Strategic Education, Inc.\">STRA</a>, <a href=\"https://seekingalpha.com/symbol/COCO\" title=\"Corinthian Colleges, Inc.\">COCO</a>, <a href=\"https://seekingalpha.com/symbol/ESI-OLD\" title=\"ITT Educational Services Inc.\">ESI-OLD</a>, <a href=\"https://seekingalpha.com/symbol/ITT\" title=\"ITT, Inc.\">ITT</a>, <a href=\"https://seekingalpha.com/symbol/BPI\" title=\"Bridgepoint Education, Inc.\">BPI</a>, <a href=\"https://seekingalpha.com/symbol/LINC\" title=\"Lincoln Educational Services Corporation\">LINC</a>, DV.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1320152\" data-linked=\"K12 crumbles after enrollment shocker, peers on watch\" data-tweet=\"$LRN $LRN $CECO - K12 crumbles after enrollment shocker, peers on watch https://seekingalpha.com/news/1320152-k12-crumbles-after-enrollment-shocker-peers-on-watch?source=tweet\" data-url=\"https://seekingalpha.com/news/1320152-k12-crumbles-after-enrollment-shocker-peers-on-watch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320062\" data-ts=\"1381319204\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STP\" target=\"_blank\">STP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320062-chinese-solar-cell-makers-bid-for-suntechs-main-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chinese solar cell makers bid for Suntech&#39;s main unit</a></h4><ul>     <li>Suntech Power (NYSE:<a href=\"https://seekingalpha.com/symbol/STP\" title=\"Suntech Power Holdings Co., Ltd.\">STP</a>) <font color=\"green\">+11.7%</font> premarket after two Chinese solar power manufacturers <a href=\"http://www.ft.com/intl/cms/s/0/8aac71a0-30bf-11e3-b478-00144feab7de.html#axzz2hDvkdbXZ\" target=\"_blank\">tender bids</a> for the main unit of the troubled company, <em>FT</em> reports, as officials attempt to cobble together a bankruptcy settlement.</li>     <li>One bid came from Hong Kong-listed Shunfeng Photovoltaic, which is offering an equity stake in STP\u2019s bankrupt Wuxi unit and a proposal to restructure the group\u2019s near-$2B in debt; the other reportedly came from from a consortium comprising GCL-Poly Energy and the investment arm of STP\u2019s home city Wuxi.</li>     <li>Any deal will be closely watched by STP's international creditors, since it likely will determine whether any money can be reclaimed.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1320062\" data-linked=\"Chinese solar cell makers bid for Suntech&#39;s main unit\" data-tweet=\"$STP - Chinese solar cell makers bid for Suntech&#39;s main unit https://seekingalpha.com/news/1320062-chinese-solar-cell-makers-bid-for-suntechs-main-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/1320062-chinese-solar-cell-makers-bid-for-suntechs-main-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1320042\" data-ts=\"1381318803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARIA\" target=\"_blank\">ARIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1320042-ariad-shares-plunge-after-it-pauses-enrollment-for-leukemia-drug-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ariad shares plunge after it pauses enrollment for leukemia drug trial</a></h4><ul>   <li>Ariad Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a>) <font color=\"red\">collapses 59%</font> after the company says that it's suspending the enrollment of new patients in trials for its Iclusig treatment for chronic myeloid leukemia.</li>    <li>The pause follows an increase in the rate of cardiac problems in patients who received Iclusig.</li>    <li>Pending FDA approval, Ariad hopes to resume enrollment with lower doses of the drug. Patients already on the medicine will continue to do so but with smaller doses.</li>    <li>The U.S. prescribing information for Iclusig remains unchanged. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1320042\" data-linked=\"Ariad shares plunge after it pauses enrollment for leukemia drug trial\" data-tweet=\"$ARIA - Ariad shares plunge after it pauses enrollment for leukemia drug trial https://seekingalpha.com/news/1320042-ariad-shares-plunge-after-it-pauses-enrollment-for-leukemia-drug-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/1320042-ariad-shares-plunge-after-it-pauses-enrollment-for-leukemia-drug-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319992\" data-ts=\"1381318261\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRN\" target=\"_blank\">LRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319992-k12-downgraded-by-bmo-capital-shares-slump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">K12 downgraded by BMO Capital, shares slump</a></h4><ul> <li>BMO Capital <a href=\"http://www.streetinsider.com/Analyst+Comments/BMO+Capital+Cuts+K12%2C+Inc.+%28LRN%29+to+Market+Perform%2C+Slashes+PT/8762462.html\" target=\"_blank\">reduces</a> its rating on K12 (NYSE:<a href=\"https://seekingalpha.com/symbol/LRN\" title=\"K12 Inc.\">LRN</a>) to Market Perform from Outperform.</li> <li>The investment firm chops its price target almost in half to $22 after taking in the trend of slowing enrollment at the education concern.</li> <li>LRN <font color=\"red\">-11.6%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1319992\" data-linked=\"K12 downgraded by BMO Capital, shares slump\" data-tweet=\"$LRN - K12 downgraded by BMO Capital, shares slump https://seekingalpha.com/news/1319992-k12-downgraded-by-bmo-capital-shares-slump?source=tweet\" data-url=\"https://seekingalpha.com/news/1319992-k12-downgraded-by-bmo-capital-shares-slump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319972\" data-ts=\"1381318002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDO\" target=\"_blank\">FDO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319972-dollar-store-group-on-watch-after-family-dollar-reports\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dollar store group on watch after Family Dollar reports</a></h4><ul> <li>Shares of Family Dollar (NYSE:<a href=\"https://seekingalpha.com/symbol/FDO\" title=\"Family Dollar Stores Inc.\">FDO</a>) <font color=\"red\">slip 1.5%</font> premarket after the company <a href=\"https://seekingalpha.com/currents/post/1319862\" target=\"_blank\">beats</a> profit estimates for FQ4, but sets uninspiring guidance for FY14.</li> <li>The company says it sees a low-single-digit increase in comparable store sales for FY14.</li> <li>In what could be an alarming trend, retail analyst Rahul Sharma <a href=\"https://twitter.com/Retail_Guru/status/387898062456487936\" target=\"_blank\">notes</a> the Family Dollar sold margin up even with low-margin food sales rising.</li> <li>On watch: Dollar General (NYSE:<a href=\"https://seekingalpha.com/symbol/DG\" title=\"Dollar General Corporation\">DG</a>), Dollar Tree (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DLTR\" title=\"Dollar Tree, Inc.\">DLTR</a>), Five Below (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FIVE\" title=\"Five Below\">FIVE</a>).</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1319972\" data-linked=\"Dollar store group on watch after Family Dollar reports\" data-tweet=\"$FDO $FDO $DG - Dollar store group on watch after Family Dollar reports https://seekingalpha.com/news/1319972-dollar-store-group-on-watch-after-family-dollar-reports?source=tweet\" data-url=\"https://seekingalpha.com/news/1319972-dollar-store-group-on-watch-after-family-dollar-reports\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319962\" data-ts=\"1381317953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319962-lexicon-slumps-after-poor-colitis-trial-result\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lexicon slumps after poor colitis trial result</a></h4><ul>   <li>Lexicon Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LXRX\" title=\"Lexicon Pharmaceuticals, Inc.\">LXRX</a>) <font color=\"red\">craters 17%</font> after the company says that its Telotristat Etiprate treatment appears to have had little effect on the mechanism that causes ulcerative colitis in a pilot study of 59 patients. That was the standard required for Lexicon to continue developing the drug for the stomach problem.</li>    <li>The company will now maintain its focus on the Phase III trial of Telotristat Etiprate for its use to treat carcinoid syndrome, which is a <a href=\"http://www.webmd.com/cancer/features/what-is-carcinoid-syndrome\" target=\"_blank\">set of symptoms</a> caused by some carcinoid tumors. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1319962\" data-linked=\"Lexicon slumps after poor colitis trial result\" data-tweet=\"$LXRX - Lexicon slumps after poor colitis trial result https://seekingalpha.com/news/1319962-lexicon-slumps-after-poor-colitis-trial-result?source=tweet\" data-url=\"https://seekingalpha.com/news/1319962-lexicon-slumps-after-poor-colitis-trial-result\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319802\" data-ts=\"1381310701\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319802-global-stocks-higher-as-investors-mull-prospects-of-yellen-as-fed-chief\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global stocks higher as investors mull prospects of Yellen as Fed chief</a></h4><ul>   <li>Global equities are looking decidedly positive as markets <a href=\"http://www.bloomberg.com/news/2013-10-08/asian-futures-drop-on-u-s-gridlock-as-gas-extends-climb.html\" target=\"_blank\">weigh the prospect</a> of the dovish Janet Yellen becoming the Chairperson of the Fed against the continuing deadlock in Washington over the federal budget and debt cap.</li>     <li>The release of the FOMC minutes today should provide further insight into the Fed's thinking.</li>    <li>Japan <font color=\"green\">+1%</font>, Hong Kong <font color=\"red\">-0.6%</font> , China <font color=\"green\">+0.6%</font>, India <font color=\"green\">+1.15%</font>.</li>    <li>EU Stocks 50 <font color=\"green\">+0.5%</font>, London <font color=\"red\">-0.1%</font>, Paris <font color=\"green\">+0.6%</font>, Frankfurt <font color=\"green\">+0.1%</font>, Madrid <font color=\"green\">+0.8%</font>, Milan <font color=\"green\">+1.1%</font>.</li>    <li>U.S. stock futures: Dow <font color=\"green\">+0.3%</font>. S&amp;P <font color=\"green\">+0.4%</font>. Nasdaq <font color=\"green\">+0.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1319802\" data-linked=\"Global stocks higher as investors mull prospects of Yellen as Fed chief\" data-tweet=\"Global stocks higher as investors mull prospects of Yellen as Fed chief https://seekingalpha.com/news/1319802-global-stocks-higher-as-investors-mull-prospects-of-yellen-as-fed-chief?source=tweet\" data-url=\"https://seekingalpha.com/news/1319802-global-stocks-higher-as-investors-mull-prospects-of-yellen-as-fed-chief\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319782\" data-ts=\"1381308787\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319782-u-k-trade-deficit-narrows-industrial-production-falls\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.K. trade deficit narrows, industrial production falls</a></h4><ul>   <li>U.K total trade deficit £3.32B in August vs £3.45B in July and consensus of £2.05B.</li>    <li>Goods trade deficit £9.625B vs £9.94B and £9B.</li>    <li>Exports of goods +1.1% on month to £25.1B, imports -0.1% to £34.7B. (PR)</li>    <li>Industrial production -1.1% on month vs +0.1% in July and consensus of +0.4%.</li>    <li>On year, industrial production -1.5% vs -1.1% and -0.6%.</li>    <li>Manufacturing production -1.2% on month vs +0.2% and +0.4%.</li>    <li>On year, manufacturing production -0.2% vs -0.3% and +1%. (PR)</li>    <li>The pound takes a tumble and the GBP-USD is now <font color=\"red\">-0.7%</font> to $1.5976. The FTSE is <font color=\"red\">-0.2%</font>.</li>     <li>ETFs - Stocks: <a href=\"https://seekingalpha.com/symbol/fku\" title=\"First Trust United Kingdom AlphaDex ETF\">FKU</a>, <a href=\"https://seekingalpha.com/symbol/ewu\" title=\"iShares MSCI United Kingdom ETF\">EWU</a>, <a href=\"https://seekingalpha.com/symbol/ewus\" title=\"iShares MSCI United Kingdom Small Cap Index ETF\">EWUS</a>, <a href=\"https://seekingalpha.com/symbol/dxps\" title=\"WisdomTree United Kingdom Hedged Equity ETF\">DXPS</a>. Currency: <a href=\"https://seekingalpha.com/symbol/gbb\" title=\"iPath GBP/USD Exchange Rate ETN\">GBB</a>, <a href=\"https://seekingalpha.com/symbol/fxb\" title=\"CurrencyShares British Pound Sterling Trust ETF\">FXB</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1319782\" data-linked=\"U.K. trade deficit narrows, industrial production falls\" data-tweet=\"$FKU $EWU $EWUS - U.K. trade deficit narrows, industrial production falls https://seekingalpha.com/news/1319782-u-k-trade-deficit-narrows-industrial-production-falls?source=tweet\" data-url=\"https://seekingalpha.com/news/1319782-u-k-trade-deficit-narrows-industrial-production-falls\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319762\" data-ts=\"1381306580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319762-french-government-warns-alcatel-lucent-over-job-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">French government warns Alcatel-Lucent over job cuts</a></h4><ul>   <li>French Prime Minister Jean-Marc Ayrault has warned Alcatel-Lucent (ALU) that authorities <a href=\"http://www.reuters.com/article/2013/10/09/us-alcatel-jobs-idUSBRE99806O20131009\" target=\"_blank\">won't approve</a> its planned layoffs in the country unless the telecom-equipment maker negotiates a good a deal with unions, and saves as many jobs and sites as possible.</li>    <li>Alcatel-Lucent yesterday unveiled a program to <a href=\"https://seekingalpha.com/currents/post/1317782\" target=\"_blank\">slash 10,000 positions</a>, including 900 in France.</li>    <li>A law passed in May makes it easier for companies to fire staff but forces them to negotiate with workers. Any agreement must be authorized by authorities.</li>    <li>Alcatel-Lucent's shares are <font color=\"red\">-5.7%</font> in Paris.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1319762\" data-linked=\"French government warns Alcatel-Lucent over job cuts\" data-tweet=\"$NOK - French government warns Alcatel-Lucent over job cuts https://seekingalpha.com/news/1319762-french-government-warns-alcatel-lucent-over-job-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/1319762-french-government-warns-alcatel-lucent-over-job-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":48,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}